BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth-quarter, the German biotech firm said as it reaffirmed its vaccine-revenue forecast for the year.
Suscribirse a:
Enviar comentarios (Atom)
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook